| Company Name: |
LGM Pharma |
| Tel: |
1-(800)-881-8210 |
| Email: |
inquiries@lgmpharma.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
|
| | Balanol Basic information |
| Product Name: | Balanol | | Synonyms: | (3R-trans)-Balanol;4-(2-Carboxy-6-hydroxybenzoyl)-3,5-dihydroxybenzoic Acid (3R,4R)-Hexahydro-3-[(4-hydroxybenzoyl)aMino]-1H-azepin-4-yl Ester;4-[2-[[[Hexahydro-4-[(4-hydroxybenzoyl)oxy]-1H-azepin-3-yl]amino]carbonyl]-6-hydroxybenzoyl]-3,5-dihydroxybenzoic acid;Benzoic acid, 4-(2-carboxy-6-hydroxybenzoyl)-3,5-dihydroxy-, (3R,4R)-hexahydro-3-[(4-hydroxybenzoyl)amino]-1H-azepin-4-yl ester;(-)-Balanol;Ophiocordin;Balanol | | CAS: | 63590-19-2 | | MF: | C28H26N2O10 | | MW: | 550.51 | | EINECS: | | | Product Categories: | Aromatics;Chiral Reagents;Heterocycles;Inhibitor;Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 63590-19-2.mol |  |
| | Balanol Chemical Properties |
| | Balanol Usage And Synthesis |
| Uses | Balanol, a fungal metabolite, is a potent ATP-competitive inhibitor of Protein Kinase C (PKC) and Protein Kinase A (PKA), important targets in oncology. | | IC 50 | Human PKCα: 4-9 nM (); PKC-βI: 4-9 nM (); PKC-βII: 4-9 nM (); Human PKCγ: 4-9 nM (); Human PKCδ: 4-9 nM (); Human PKCε: 4-9 nM (); human PKCη: 150 nM (); PKA |
| | Balanol Preparation Products And Raw materials |
|